## **Core Concept**
Prophylactic anti-D immunoglobulin administration is a crucial preventive measure for Rh-negative pregnant women to prevent isoimmunization, which can lead to hemolytic disease of the newborn (HDN). The goal is to suppress the immune response to Rh-positive fetal red blood cells that may enter the maternal circulation.

## **Why the Correct Answer is Right**
The correct timing for administering prophylactic anti-D injection in non-immunized Rh-negative women is at 28 weeks of gestation. This is because the risk of fetomaternal hemorrhage (FMH) increases as the pregnancy advances, and administering anti-D at this time helps to prevent sensitization. Additionally, a second dose is often given postpartum if the baby is Rh-positive. The anti-D immunoglobulin works by binding to any Rh-positive red blood cells that may have entered the maternal circulation, thereby preventing an immune response against these cells.

## **Why Each Wrong Option is Incorrect**
- **Option A:** 20 weeks - This is too early for routine prophylactic anti-D administration. While some protocols may recommend testing for FMH and considering early administration in cases of potential exposure, routine administration at 20 weeks is not standard.
- **Option B:** 32 weeks - Although close to the correct timeframe, waiting until 32 weeks might delay necessary protection against isoimmunization.
- **Option D:** Immediately postpartum - While a postpartum dose is often administered to Rh-negative mothers if the baby is Rh-positive, relying solely on immediate postpartum administration misses the preventive window during pregnancy.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that the 28-week anti-D prophylaxis is a standard recommendation for Rh-negative pregnant women, along with a postpartum dose if the newborn is Rh-positive. This strategy significantly reduces the risk of Rh isoimmunization and its complications.

## **Correct Answer:** . 28 weeks.